Literature DB >> 2416906

Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.

S M Simasko, J R Soares, G A Weiland.   

Abstract

The inhibition of carbamylcholine-stimulated 22Na+ flux by substance P and various peptide analogs was examined in PC12 cells, a line which contains a neuronal-type nicotinic receptor, and BC3H1 cells, a line which contains a muscle-type nicotinic receptor. Substance P produces a noncompetitive inhibition of carbamylcholine-stimulated 22Na+ influx in both cell lines (IC50 = 1.2 microM on PC12 cells and 8.2 microM on BC3H1 cells). The structure-activity relation for substance P analogs was qualitatively similar in both cell lines; however, there were quantitative differences. Substance P was the most potent peptide tested. Analogs of substance P with amino acids removed from the N-terminus resulted in significant decreases in potency, whereas removal of amino acids from the C-terminus resulted in analogs virtually devoid of activity. Compounds purported to be substance P antagonists had actions similar to substance P in reducing carbamylcholine-stimulated 22Na+ flux. The related tachykinins physalaemin and eledoisin had low potencies on both cell lines. These results indicate that the site through which substance P exerts its inhibitory effects on activation of nicotinic receptors is different from the receptors described previously for substance P in more classical systems. In addition, our results indicate that substance P has an effect on both the neuronal-type nicotinic receptor (alpha-bungarotoxin insensitive) expressed on PC12 cells and the muscle-type nicotinic receptor (alpha-bungarotoxin sensitive) expressed on BC3H1 cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416906

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

Review 2.  Noncholinergic control of adrenal catecholamine secretion.

Authors:  B G Livett; P D Marley
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

3.  Substance P modulates the time course of nicotinic but not muscarinic catecholamine secretion from perfused adrenal glands of rat.

Authors:  X F Zhou; P D Marley; B G Livett
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 4.  Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Authors:  E L Ochoa; L Li; M G McNamee
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 5.  Regulation of nicotinic acetylcholine receptors by protein phosphorylation.

Authors:  K Miles; R L Huganir
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

6.  Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.

Authors:  R J Lukas; C M Eisenhour
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

7.  Calcitonin gene-related peptide rapidly downregulates nicotinic receptor function and slowly raises intracellular Ca2+ in rat chromaffin cells in vitro.

Authors:  R Giniatullin; S Di Angelantonio; C Marchetti; E Sokolova; L Khiroug; A Nistri
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

8.  Substance P increases catecholamine secretion from perfused rat adrenal glands evoked by prolonged field stimulation.

Authors:  X F Zhou; B G Livett
Journal:  J Physiol       Date:  1990-06       Impact factor: 5.182

9.  Pharmacological profile of a tachykinin antagonist, spantide, as examined on rat spinal motoneurones.

Authors:  M Yanagisawa; M Otsuka
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

10.  Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.

Authors:  J W Daly; Y Nishizawa; M W Edwards; J A Waters; R S Aronstam
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.